ARGENX Trademark
Trademark Overview
On Monday, January 13, 2025, a trademark application was filed for ARGENX with the United States Patent and Trademark Office. The USPTO has given the ARGENX trademark a serial number of 98957449. The federal status of this trademark filing is REGISTERED as of Tuesday, June 9, 2026. This trademark is owned by Argenx B.V.. The ARGENX trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Wholesale and retail store services for therapeutic pharmaceutical preparations in the field of immunology and auto-immune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; business administrative services in relation to patient information in the field of immunology, diseases of the immune system and antibody therapeutics; business administration of patient reimbursement programs
Providing information to patients in the field of auto-immune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system and the treatment thereof; medical consultancy and information services relating to therapeutic biopharmaceutical products; Provision of medical information on therapeutic pharmaceutical, medical, and healthcare products to customers or patients through an online computer network
Research and development in the field of immunology, antibody engineering and autoimmune diseases for therapeutic purposes; therapeutic drug research and development in the field of immunology, antibody technology and autoimmune diseases; scientific and technological services, namely, research relating to immunity, autoimmune diseases and antibody engineering for therapeutic purposes; providing medical and scientific research information in the field of therapeutic pharmaceuticals, clinical trials, research and development
Pharmaceuticals and medical preparations for therapeutic purposes in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, transplantation-related diseases and disorders, cancer and diseases of the immune system
General Information
| Serial Number | 98957449 |
| Word Mark | ARGENX |
| Filing Date | Monday, January 13, 2025 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 9, 2026 |
| Registration Number | 8290605 |
| Registration Date | Tuesday, June 9, 2026 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 21, 2026 |
Trademark Statements
| In Another Form Statement | The mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/00/2008. |
| Goods and Services | Wholesale and retail store services for therapeutic pharmaceutical preparations in the field of immunology and auto-immune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; business administrative services in relation to patient information in the field of immunology, diseases of the immune system and antibody therapeutics; business administration of patient reimbursement programs |
| In Another Form Statement | The mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/00/2008. |
| Goods and Services | Providing information to patients in the field of auto-immune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system and the treatment thereof; medical consultancy and information services relating to therapeutic biopharmaceutical products; Provision of medical information on therapeutic pharmaceutical, medical, and healthcare products to customers or patients through an online computer network |
| In Another Form Statement | The mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/00/2008. |
| In Another Form Statement | The mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/00/2008. |
| In Another Form Statement | The mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/00/2008. |
| In Another Form Statement | The mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/00/2008. |
| Goods and Services | Research and development in the field of immunology, antibody engineering and autoimmune diseases for therapeutic purposes; therapeutic drug research and development in the field of immunology, antibody technology and autoimmune diseases; scientific and technological services, namely, research relating to immunity, autoimmune diseases and antibody engineering for therapeutic purposes; providing medical and scientific research information in the field of therapeutic pharmaceuticals, clinical trials, research and development |
| In Another Form Statement | The mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/00/2008. |
| In Another Form Statement | The mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/00/2008. |
| Goods and Services | Pharmaceuticals and medical preparations for therapeutic purposes in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, transplantation-related diseases and disorders, cancer and diseases of the immune system |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 13, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, December 17, 2021 |
| First Use In Commerce Date | Friday, December 17, 2021 |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 13, 2025 |
| Primary Code | 035 |
| First Use Anywhere Date | Friday, December 17, 2021 |
| First Use In Commerce Date | Friday, December 17, 2021 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 13, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, November 10, 2015 |
| First Use In Commerce Date | Tuesday, November 10, 2015 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 13, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | Monday, June 1, 2020 |
| First Use In Commerce Date | Monday, June 1, 2020 |
Trademark Owner History
| Party Name | Argenx B.V. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Zwijnaarde B-9052
BE |
| Party Name | Argenx B.V. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Zwijnaarde B-9052
BE |
| Party Name | Argenx B.V. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Zwijnaarde B-9052
BE |
Trademark Events
| Event Date | Event Description |
| Monday, January 13, 2025 | NEW APPLICATION ENTERED |
| Wednesday, June 11, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, June 19, 2025 | ASSIGNED TO EXAMINER |
| Thursday, June 19, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, June 19, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, June 19, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 17, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, September 17, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Friday, December 19, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 19, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 19, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 13, 2026 | SUSPENSION LETTER WRITTEN |
| Friday, February 13, 2026 | LETTER OF SUSPENSION E-MAILED |
| Friday, February 13, 2026 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, March 19, 2026 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, March 19, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, March 19, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, March 25, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 15, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 21, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 21, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 9, 2026 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 9, 2026 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
